Market Overview:
The global preclinical tomography system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for preclinical tomography systems from biopharmaceutical companies and research institutes across the globe. In addition, the growing adoption of composite systems is also contributing to the growth of this market. However, factors such as high cost and lack of skilled professionals are restraining the growth of this market. On the basis of type, CT scanners accounted for a major share in 2017 and are expected to continue its dominance during the forecast period. This can be attributed to their ability to provide high-resolution images with good contrast resolution that helps in accurate diagnosis and treatment planning for various diseases.
Product Definition:
Preclinical tomography system is a medical imaging technique that uses X-rays to produce three-dimensional images of the inside of an object. It is used to diagnose and treat medical conditions.
CT:
CT or computed tomography is a diagnostic medical imaging technology that utilizes X-rays to produce 3D images of internal body organs and tissues. CT scans are painless, require little to no radiation exposure, and can provide detailed information on the structure and function of complex organs.
PET&SPECT:
PET & SPECT are two different Tomography systems used in preclinical imaging. PET is an expensive and complex system which helps in studying molecular mechanisms whereas the simpler and cost-effective spectroscopic imaging technique, known as Single Photon Emission Computed Tomography (SPECT) is used for clinical purposes.
Application Insights:
The biopharmaceuticals segment dominated the global preclinical tomography system market in terms of revenue in 2017. The growth can be attributed to the increasing usage of these systems for drug development and testing. Preclinical imaging helps visualize tissue morphology, composition, and physiology during various stages of clinical trials. It also provides information about tumor biology including proliferation rates, metastasis potential, angiogenesis ability & activity as well as invasiveness. These factors are taken into consideration while designing future trials for cancer treatment or diagnosis purposes.
CT is widely used for preclinical imaging due to its ability to provide detailed images of soft tissue structures with high spatial resolution than other modalities such as MRI or ultrasound does at a cheaper cost compared to these devices (composite).
Regional Analysis:
North America dominated the global preclinical tomography system market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for new technologies, and increasing R&D expenditure by companies. The region is expected to maintain its dominance throughout the forecast period owing to continuous technological advancements and growing biopharmaceutical industry in this region. Asia Pacific is anticipated to grow at a lucrative CAGR during the forecast period due to increasing government funding for medical & healthcare research projects along with rising awareness about clinical trials in emerging countries such as China & India.
Major players operating in this industry include GE Healthcare; Siemens Healthineers; Philips Healthcare; PerkinElmer Inc.; Hitachi, Ltd.; Toshiba Medical Systems Corporation; Koninklijke Philips N.V.
Growth Factors:
- Increasing demand for better and faster drug discovery and development processes is expected to drive the Preclinical Tomography System market growth.
- The increasing use of preclinical tomography systems for 3D cell culture analysis is also anticipated to fuel the market growth in the near future.
- Rising number of research institutes and universities are expected to create new opportunities for the Preclinical Tomography System market in coming years.
- Growing investments by key players in R&D activities is likely to propel the Preclinical Tomography System market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Preclinical Tomography System Market Research Report
By Type
CT, PET&SPECT, Composite System
By Application
Biopharmaceuticals, Research Institute, Other
By Companies
Bruker, SEDECAL, MR Solutions, Scanco Medical, PerkinElmer, Mediso, MILabs, Trifoil Imaging
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Preclinical Tomography System Market Report Segments:
The global Preclinical Tomography System market is segmented on the basis of:
Types
CT, PET&SPECT, Composite System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceuticals, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bruker
- SEDECAL
- MR Solutions
- Scanco Medical
- PerkinElmer
- Mediso
- MILabs
- Trifoil Imaging
Highlights of The Preclinical Tomography System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CT
- PET&SPECT
- Composite System
- By Application:
- Biopharmaceuticals
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preclinical Tomography System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A preclinical tomography system (CT) is a medical imaging device that uses X-rays to create images of the body. CT scans are used to diagnose and monitor diseases, injuries, and other conditions in the body.
Some of the major companies in the preclinical tomography system market are Bruker, SEDECAL, MR Solutions, Scanco Medical, PerkinElmer, Mediso, MILabs, Trifoil Imaging.
The preclinical tomography system market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Preclinical Tomography System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Preclinical Tomography System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Preclinical Tomography System Market - Supply Chain
4.5. Global Preclinical Tomography System Market Forecast
4.5.1. Preclinical Tomography System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Preclinical Tomography System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Preclinical Tomography System Market Absolute $ Opportunity
5. Global Preclinical Tomography System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Preclinical Tomography System Market Size and Volume Forecast by Type
5.3.1. CT
5.3.2. PET&SPECT
5.3.3. Composite System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Preclinical Tomography System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Preclinical Tomography System Market Size and Volume Forecast by Application
6.3.1. Biopharmaceuticals
6.3.2. Research Institute
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Preclinical Tomography System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Preclinical Tomography System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Preclinical Tomography System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Preclinical Tomography System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Preclinical Tomography System Demand Share Forecast, 2019-2029
9. North America Preclinical Tomography System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Preclinical Tomography System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Preclinical Tomography System Market Size and Volume Forecast by Application
9.4.1. Biopharmaceuticals
9.4.2. Research Institute
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Preclinical Tomography System Market Size and Volume Forecast by Type
9.7.1. CT
9.7.2. PET&SPECT
9.7.3. Composite System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Preclinical Tomography System Demand Share Forecast, 2019-2029
10. Latin America Preclinical Tomography System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Preclinical Tomography System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Preclinical Tomography System Market Size and Volume Forecast by Application
10.4.1. Biopharmaceuticals
10.4.2. Research Institute
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Preclinical Tomography System Market Size and Volume Forecast by Type
10.7.1. CT
10.7.2. PET&SPECT
10.7.3. Composite System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Preclinical Tomography System Demand Share Forecast, 2019-2029
11. Europe Preclinical Tomography System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Preclinical Tomography System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Preclinical Tomography System Market Size and Volume Forecast by Application
11.4.1. Biopharmaceuticals
11.4.2. Research Institute
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Preclinical Tomography System Market Size and Volume Forecast by Type
11.7.1. CT
11.7.2. PET&SPECT
11.7.3. Composite System 11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Preclinical Tomography System Demand Share, 2019-2029
12. Asia Pacific Preclinical Tomography System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Preclinical Tomography System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Preclinical Tomography System Market Size and Volume Forecast by Application
12.4.1. Biopharmaceuticals
12.4.2. Research Institute
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Preclinical Tomography System Market Size and Volume Forecast by Type
12.7.1. CT
12.7.2. PET&SPECT
12.7.3. Composite System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Preclinical Tomography System Demand Share, 2019-2029
13. Middle East & Africa Preclinical Tomography System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Preclinical Tomography System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Preclinical Tomography System Market Size and Volume Forecast by Application
13.4.1. Biopharmaceuticals
13.4.2. Research Institute
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Preclinical Tomography System Market Size and Volume Forecast by Type
13.7.1. CT
13.7.2. PET&SPECT
13.7.3. Composite System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Preclinical Tomography System Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Preclinical Tomography System Market: Market Share Analysis
14.2. Preclinical Tomography System Distributors and Customers
14.3. Preclinical Tomography System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bruker
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SEDECAL
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MR Solutions
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Scanco Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. PerkinElmer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mediso
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MILabs
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Trifoil Imaging
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
